Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
08:40:50 EDT Tue 14 Apr 2026
Enter Symbol
or Name
USA
CA



Forgot password?
Trouble logging in?
Login ID:
Password:
Save

News for U:QTRX from 2025-04-15 to 2026-04-14 - 31 items News ReleasesIn The NewsOther CAUS
DateSymPriceTypeHeadline
2026-03-27 16:00U:QTRXNews ReleaseQuanterix Corporation Announces Date of 2026 Annual Meeting
2026-03-02 16:01U:QTRXNews ReleaseQuanterix Releases Financial Results for the Fourth Quarter and Full Year 2025
2026-03-02 08:33U:QTRXNews ReleaseLucent Diagnostics and Life Line Screening Partner to Bring Advanced Blood-Based Diagnostics to Communities Nationwide
2026-02-26 08:33U:QTRXNews ReleaseQuanterix to Participate in Upcoming Investor Conferences
2026-02-20 08:33U:QTRXNews ReleaseQuanterix To Report Fourth Quarter and Full Year 2025 Financial Results on March 2, 2026
2026-02-03 08:33U:QTRXNews ReleaseQuanterix Announces FDA 510(k) Submission for a Multi-Analyte Algorithmic Blood Test for Alzheimer's Disease Detection
2026-01-21 08:33U:QTRXNews ReleaseQuanterix Announces Landmark JAMA Study Highlighting Prognostic Value of Multi-Analyte Approach to Blood-Based Alzheimer's Risk Profiling
2026-01-16 16:01U:QTRXNews ReleaseQuanterix Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2026-01-08 16:30U:QTRXNews ReleaseQuanterix Appoints Everett Cunningham as President and CEO Effective January 19, 2026
2025-12-22 07:30U:QTRXNews ReleaseQuanterix Announces Landmark Nature Study Redefining Alzheimer's Disease Neuropathology Prevalence
2025-11-20 16:15U:QTRXNews ReleaseQuanterix Announces Board and Leadership Changes to Support Next Stage of Growth
2025-11-17 17:30U:QTRXNews ReleaseQuanterix Announces Landmark Study Demonstrating Dual GFAP/NfL Blood Test Approach for Personalized Multiple Sclerosis Monitoring
2025-11-10 16:01U:QTRXNews ReleaseQuanterix Releases Financial Results for the Third Quarter of 2025
2025-11-03 07:00U:QTRXNews ReleaseQuanterix To Report Third Quarter 2025 Financial Results on November 10, 2025
2025-08-21 16:30U:QTRXNews ReleaseQuanterix Accelerator Laboratory Awarded Rigorous New York State Clinical Laboratory Permit
2025-08-11 07:00U:QTRXNews ReleaseQuanterix to Present at the Canaccord Genuity 45th Annual Growth Conference
2025-08-07 16:06U:QTRXNews ReleaseQuanterix Releases Financial Results for the Second Quarter of 2025
2025-08-04 16:02U:QTRXNews ReleaseQuanterix To Report Second Quarter 2025 Financial Results on August 7, 2025
2025-08-04 09:30U:QTRXNews ReleaseQuanterix Announces Cooperation Agreement with Kent Lake Capital
2025-07-28 07:00U:QTRXNews ReleaseQuanterix Launches Novel p-Tau 205 and p-Tau 212 Assays to Advance Alzheimer's Research at AAIC
2025-07-11 17:00U:QTRXNews ReleaseQuanterix Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2025-07-08 09:07U:QTRXNews ReleaseQuanterix Completes Acquisition of Akoya Biosciences, Creating the First Integrated Platform Capable of Measuring Biomarkers Across the Blood and Tissue Continuum
2025-06-23 07:30U:QTRXNews ReleaseQuanterix Expands Reach with IVD and Large Reference Labs
2025-06-11 08:00U:QTRXNews ReleaseKent Lake Condemns Quanterix's Failure to Schedule Its 2025 Annual Meeting as a Tactic to Silence Shareholders
2025-06-06 09:41U:QTRXNews ReleaseQuanterix to Present at Goldman Sachs Global Healthcare Conference
2025-05-23 14:21U:QTRXNews ReleaseKent Lake Responds to Quanterix's Post-Effective Amendment and Akoya's Superior $1.40-per-Share Alternative Proposal
2025-05-12 16:01U:QTRXNews ReleaseQuanterix Releases Financial Results for the First Quarter of 2025
2025-05-05 07:00U:QTRXNews ReleaseQuanterix To Report First Quarter 2025 Financial Results on May 12, 2025
2025-04-30 08:00U:QTRXNews ReleaseKent Lake Issues Statement on Quanterix's Blatant Disregard for Will of Shareholders
2025-04-29 07:00U:QTRXNews ReleaseQuanterix and Akoya Biosciences Announce Amended Merger Agreement
2025-04-17 08:30U:QTRXNews ReleaseKent Lake Files Definitive Proxy Statement and Sends Letter to Quanterix Shareholders